Intermediate-to-High Risk Differentiated Thyroid Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Intermediate-to-High Risk Differentiated Thyroid Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 3

NCT07239674

Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC

The global incidence of Differentiated Thyroid Cancer (DTC) is rising. While surgery followed by TSH suppression is the standard of care, achieving target TSH l…

Location not specified646 participantsStarted 2025-11-30

Treatment: desiccated thyroid extract (DTE)+levothyroxine (L-T4)